
无数据
无数据
无数据
| CAS Number | 82248-59-7 |
| Catalog Number | AG00500D(AGN-PC-0ULNUW) |
| Chemical Name | Atomoxetine, HCl |
| IUPAC Name | (3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine;hydrochloride |
| InChI | InChI=1S/C17H21NO.ClH/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15;/h3-11,17-18H,12-13H2,1-2H3;1H/t17-;/m1./s1 |
| InChI Key | LUCXVPAZUDVVBT-UNTBIKODSA-N |
| MDL Number | MFCD06410992 |
| Molecular Formula | C17H21ClNO |
| Molecular Weight | 291.8157 |
| SMILES | [C@H](OC1=C(C=CC=C1)C)(C2=CC=CC=C2)CCNC.[H+].[Cl-] |
| UNII | 57WVB6I2W0 |
| Synonyms | 139603, LY,
atomoxetine,
Atomoxetine HCl,
atomoxetine hydrochloride,
HCl, Atomoxetine,
Hydrochloride, Atomoxetine,
LY 139603,
N-methyl-gamma-(2-methylphenoxy)benzenepropanamine hydrochloride,
Strattera,
tomoxetine,
Tomoxetine Hydrochloride, (+)-isomer - T351671,
tomoxetine hydrochloride, (+-)-isomer,
tomoxetine hydrochloride, (-)-isomer,
Atomoxetine HCL,
Atomoxetine hydrochloride,
82248-59-7,
Strattera,
TOMOXETINE HYDROCHLORIDE,
(R)-Tomoxetine hydrochloride,
(R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride,
LY 139603,
(R)-(-)-Tomoxetine hydrochloride,
Atomoxetine (hydrochloride),
UNII-57WVB6I2W0,
Atomoxetine hydrochloride [USAN],
LY-139603,
57WVB6I2W0,
CHEBI:331697,
MFCD06410992,
(-)-N-Methyl-3-phenyl-3-(o-tolyloxy)propylamine hydrochloride,
C17H21NO.HCl,
DSSTox_CID_24266,
DSSTox_RID_80136,
DSSTox_GSID_44266,
(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine hydrochloride,
Benzenepropanamine, N-methyl-gamma-(2-methylphenoxy)-, hydrochloride, (-)-,
SMR000469177,
CAS-82248-59-7,
Tomoxetine HCl,
(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine;hydrochloride,
Atomoxetine, HCl,
Strattera (TN),
tomoxetine hydrochloride, (-)-isomer,
atomoxetine-hydrochloride,
AC1L1HTF,
NCGC00016056-02,
AK-72912,
CHEMBL1702,
MLS001401377,
MLS002153176,
SCHEMBL122111,
(-)-N-methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride,
DTXSID2044266,
LUCXVPAZUDVVBT-UNTBIKODSA-N,
HMS3677C05,
(R)-Tomoxetine hydrochloride, solid,
Tox21_110292,
(R)-ATOMOXETINE HYDROCHLORIDE,
Atomoxetine hydrochloride (JAN/USP),
LY-139602 [(+)-isomer],
s3175,
AKOS015920150,
Tox21_110292_1,
AB25136,
API0001557,
CCG-100874,
CS-1085,
KS-1223,
NC00124,
SB17442,
NCGC00025345-02,
AN-11139,
AT-20429,
BR-72912,
CPD000469177,
HY-17385,
K464,
LY139603,
SAM001246626,
SC-17967,
AB0014234,
LS-177676,
LY-135252,
AM20060733,
FT-0655350,
ST24020766,
SW197504-3,
D02574,
M-1314,
248T597,
SR-01000597779,
SR-01000763397,
SR-01000597779-1,
SR-01000763397-3,
F0001-2408,
Atomoxetine Hydrochloride 1.0 mg/ml in Methanol (as free base),
(R)-N-Methyl-?-(2-methylphenoxy)-benzenepropanamine hydrochloride,
(R)-N-Methyl-3-(2-methylphenoxy)-3-phenylpropylamine Hydrochloride,
(R)-N-METHYL-3-PHENYL-3-(O-TOLYLOXY)PROPAN-1-AMINE HCL,
(3R)-N-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine hydrochloride,
(R)-(-)-N-methyl-3-(2-methylphenoxy)-3-phenylpropylamine hydrochloride,
(R)-N-Methyl-gamma-(2-methyl-phenoxy)benzenepropanamine hydrochloride,
(r)-n-methyl-gamma-(2-methylphenoxy)-benzenepropanamine hydrochloride,
Atomoxetine hydrochloride, European Pharmacopoeia (EP) Reference Standard,
METHYL-((R)-3-PHENYL-3-O-TOLYLOXY-PROPYL)-AMINE HYDROCHLORIDE,
Atomoxetine for impurity A identification, European Pharmacopoeia (EP) Reference Standard,
Atomoxetine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material,
Atomoxetine hydrochloride, United States Pharmacopeia (USP) Reference Standard,
Atomoxetine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material,
Tomoxetine,
Atomoxetine,
Not Available,
HCl, Atomoxetine,
Hydrochloride, Atomoxetine,
C17-H21-N-O.Cl-H,
CID54840,
tomoxetine hydrochloride, (+)-isomer,
tomoxetine hydrochloride, (+-)-isomer,
CS-O-14646,
139603, LY,
A2357,
B2244,
A13424,
C041930,
Tomoxetine Hydrochloride, (+)-isomer - T351671,
83015-26-3,
D000069445,
N-methyl-gamma-(2-methylphenoxy)benzenepropanamine hydrochloride,
(R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-aminehydrochloride,
Atomoxetine hydrochloride, 99%, a selective norepinephrine reuptake inhibitor - 10mg 10mg,
|
| Complexity | 237 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 2 |
| Defined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 291.139g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 20 |
| Hydrogen Bond Acceptor Count | 2 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 291.819g/mol |
| Monoisotopic Mass | 291.139g/mol |
| Rotatable Bond Count | 6 |
| Topological Polar Surface Area | 21.3A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H315-H319-H335 |
| Packing Group | Ⅲ |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

